Terbinafine Hydrochloride
Product Images NDC 31722-209

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terbinafine Hydrochloride (NDC 31722-209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3a183255-figure-01 (3a183255 Figure 01)

A table comparing the percentage of adverse events and treatment discontinuations between Lamisil and placebo groups. It lists symptoms related to headaches, gastrointestinal issues, dermatological symptoms, liver enzyme abnormalities, taste disturbance, and visual disturbance with corresponding percentages for each category.*

FDA Label Image

3a183255-figure-02 (3a183255 Figure 02)

Chemical structure of Terbinafine Hydrochloride showing the molecule's aromatic rings, double bonds, and methyl groups along with the hydrochloride component.*

FDA Label Image

3a183255-figure-03 (3a183255 Figure 03)

A partial text panel listing side effects that include nausea, stomach (abdominal) pain, rash, headache, vomiting, dizziness, and frequent urination. The text is presented in bullet points without additional context or headings visible.*

FDA Label Image

3a183255-figure-04 (3a183255 Figure 04)

Drug facts or side effects information for Terbinafine Hydrochloride, listing symptoms such as nausea, poor appetite, tiredness, vomiting, abdominal pain, jaundice, dark urine, and pale stools. The text is focused on potential adverse effects or warning signs.*

FDA Label Image

3a183255-figure-05 (3a183255 Figure 05)

Label for Terbinafine Hydrochloride tablets 250 mg, manufactured for Camber Pharmaceuticals, Inc. The label indicates a package of 100 tablets with the product NDC 31722-209-01. Storage instructions, manufacturer address, and usual adult usage information are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.